Page last updated: 2024-08-21

isoxazoles and Dyspnea

isoxazoles has been researched along with Dyspnea in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bishop, JM; Hamilton, JA	1
Arrossi, A; Modrykamien, A; Reddy, A	1
Borges, H; Frey, JG; Schnyder, JM; Tschopp, JM	1
Safdar, Z	1
Jacobi, AM; Mohr, M	1
Hwang, LJ; Jardim, C; Jerjes-Sánchez Díaz, C; Kurzyna, M; Pulido, T; Ramírez, A; Sandoval, J; Souza, R; Teal, SA; Torbicki, A	1
Baughman, RP; Lower, EE; Nunes, H; Sweiss, NJ	1
Badesch, D; Barst, RJ; Frost, A; Galie, N; Langleben, D; Lawrence, EC; Naeije, R; Shapiro, S	1
Carloni, A; Giannakakis, K; Nori, G; Piciucchi, S; Poletti, V; Zobel, BB	1

Reviews

2 review(s) available for isoxazoles and Dyspnea

Article	Year
[Referring to an unusual case: pulmonary affection and rheumatoid arthritis]. Revue medicale suisse, 2009, Nov-11, Volume: 5, Issue:225 Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchiectasis; Dyspnea; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Diseases; Middle Aged; Pleural Diseases; Pleurodesis; Pneumothorax; Pulmonary Emphysema; Radiography, Thoracic; Recurrence; Tetracycline; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2009
Established and experimental medical therapy of pulmonary sarcoidosis. The European respiratory journal, 2013, Volume: 41, Issue:6 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Dyspnea; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Positron-Emission Tomography; Quality of Life; Radiography, Thoracic; Research Design; Respiratory Function Tests; Sarcoidosis, Pulmonary; Therapies, Investigational; Treatment Outcome	2013

Article

Year

[Referring to an unusual case: pulmonary affection and rheumatoid arthritis].

Revue medicale suisse, 2009, Nov-11, Volume: 5, Issue:225

Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchiectasis; Dyspnea; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Diseases; Middle Aged; Pleural Diseases; Pleurodesis; Pneumothorax; Pulmonary Emphysema; Radiography, Thoracic; Recurrence; Tetracycline; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha

2009

Established and experimental medical therapy of pulmonary sarcoidosis.

The European respiratory journal, 2013, Volume: 41, Issue:6

Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Dyspnea; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Positron-Emission Tomography; Quality of Life; Radiography, Thoracic; Research Design; Respiratory Function Tests; Sarcoidosis, Pulmonary; Therapies, Investigational; Treatment Outcome

2013

Trials

2 trial(s) available for isoxazoles and Dyspnea

Article	Year
Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension. Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:1 Topics: Adolescent; Adult; Aged; Blood Pressure; Child; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin Receptor Antagonists; Endpoint Determination; Female; Humans; Hypertension, Pulmonary; Intention to Treat Analysis; Isoxazoles; Kaplan-Meier Estimate; Liver Function Tests; Male; Middle Aged; Pulmonary Wedge Pressure; Sample Size; Thiophenes; Treatment Outcome; Vascular Resistance; Young Adult	2012
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. Journal of the American College of Cardiology, 2006, May-16, Volume: 47, Issue:10 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bosentan; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Risk Assessment; Sulfonamides; Thiophenes; Treatment Outcome	2006

Article

Year

Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.

Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:1

Topics: Adolescent; Adult; Aged; Blood Pressure; Child; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin Receptor Antagonists; Endpoint Determination; Female; Humans; Hypertension, Pulmonary; Intention to Treat Analysis; Isoxazoles; Kaplan-Meier Estimate; Liver Function Tests; Male; Middle Aged; Pulmonary Wedge Pressure; Sample Size; Thiophenes; Treatment Outcome; Vascular Resistance; Young Adult

2012

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.

Journal of the American College of Cardiology, 2006, May-16, Volume: 47, Issue:10

Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bosentan; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Risk Assessment; Sulfonamides; Thiophenes; Treatment Outcome

2006

Other Studies

5 other study(ies) available for isoxazoles and Dyspnea

Article	Year
69-year-old woman with rheumatoid arthritis presents with shortness of breath and cough. Annals of the American Thoracic Society, 2014, Volume: 11, Issue:10 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bronchoalveolar Lavage; Bronchoscopy; Cough; Diagnosis, Differential; Dyspnea; Female; Humans; Isoxazoles; Leflunomide; Pulmonary Disease, Chronic Obstructive; Pulmonary Eosinophilia; Tomography, X-Ray Computed	2014
A 50-year-old man with stage 2 sarcoidosis with pleural involvement. Journal of hospital medicine, 2009, Volume: 4, Issue:4 Topics: Antirheumatic Agents; Dyspnea; Humans; Isoxazoles; Leflunomide; Lung; Male; Middle Aged; Pleural Diseases; Pleural Effusion; Prednisone; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome	2009
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension. Vascular health and risk management, 2011, Volume: 7 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking	2011
Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade. Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Dyspnea; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methotrexate; Middle Aged; Peptides, Cyclic; Radiography; Receptors, Interleukin-6; Rheumatoid Factor; Steroids	2011
Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis. Journal of thoracic imaging, 2008, Volume: 23, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Dyspnea; Hemoptysis; Hemorrhage; Humans; Isoxazoles; Kidney; Leflunomide; Lung; Lung Diseases; Male; Methylprednisolone; Muscle Weakness; Pleural Effusion; Pulmonary Alveoli; Tomography, X-Ray Computed	2008